203 related articles for article (PubMed ID: 30745853)
1. Attenuation of STAT3 Phosphorylation Promotes Apoptosis and Chemosensitivity in Human Osteosarcoma Induced by Raddeanin A.
Wang Z; Wang C; Zuo D; Zhang T; Yin F; Zhou Z; Wang H; Xu J; Mao M; Wang G; Hua Y; Sun W; Cai Z
Int J Biol Sci; 2019; 15(3):668-679. PubMed ID: 30745853
[TBL] [Abstract][Full Text] [Related]
2. Antitumor activity of Raddeanin A is mediated by Jun amino-terminal kinase activation and signal transducer and activator of transcription 3 inhibition in human osteosarcoma.
Wang Z; Shen J; Sun W; Zhang T; Zuo D; Wang H; Wang G; Xu J; Yin F; Mao M; Zhou Z; Hua Y; Cai Z
Cancer Sci; 2019 May; 110(5):1746-1759. PubMed ID: 30907478
[TBL] [Abstract][Full Text] [Related]
3. Raddeanin A, a natural triterpenoid saponin compound, exerts anticancer effect on human osteosarcoma via the ROS/JNK and NF-κB signal pathway.
Ma B; Zhu J; Zhao A; Zhang J; Wang Y; Zhang H; Zhang L; Zhang Q
Toxicol Appl Pharmacol; 2018 Aug; 353():87-101. PubMed ID: 29847772
[TBL] [Abstract][Full Text] [Related]
4. Alternol, a natural compound, exerts an anti-tumour effect on osteosarcoma by modulating of STAT3 and ROS/MAPK signalling pathways.
Zuo D; Zhou Z; Wang H; Zhang T; Zang J; Yin F; Sun W; Chen J; Duan L; Xu J; Wang Z; Wang C; Lin B; Fu Z; Liao Y; Li S; Sun M; Hua Y; Zheng L; Cai Z
J Cell Mol Med; 2017 Feb; 21(2):208-221. PubMed ID: 27624867
[TBL] [Abstract][Full Text] [Related]
5. G721-0282 inhibits cell growth and induces apoptosis in human osteosarcoma through down-regulation of the STAT3 pathway.
Park KR; Yun HM; Hong JT
Int J Biol Sci; 2020; 16(2):330-341. PubMed ID: 31929760
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells promote osteosarcoma cell survival and drug resistance through activation of STAT3.
Tu B; Zhu J; Liu S; Wang L; Fan Q; Hao Y; Fan C; Tang TT
Oncotarget; 2016 Jul; 7(30):48296-48308. PubMed ID: 27340780
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-221 Upregulates the Expression of P-gp and Bcl-2 by Activating the Stat3 Pathway to Promote Doxorubicin Resistance in Osteosarcoma Cells.
Liu Y; Liu X; Yang S
Biol Pharm Bull; 2021 Jun; 44(6):861-868. PubMed ID: 33828027
[TBL] [Abstract][Full Text] [Related]
8. STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma.
Tu B; Du L; Fan QM; Tang Z; Tang TT
Cancer Lett; 2012 Dec; 325(1):80-8. PubMed ID: 22743617
[TBL] [Abstract][Full Text] [Related]
9. Raddeanin A inhibits growth and induces apoptosis in human colorectal cancer through downregulating the Wnt/β-catenin and NF-κB signaling pathway.
Wang Y; Bao X; Zhao A; Zhang J; Zhang M; Zhang Q; Ma B
Life Sci; 2018 Aug; 207():532-549. PubMed ID: 29972765
[TBL] [Abstract][Full Text] [Related]
10. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
Mao M; Zhang T; Wang Z; Wang H; Xu J; Yin F; Wang G; Sun M; Wang Z; Hua Y; Cai Z
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1214-1225. PubMed ID: 30659925
[TBL] [Abstract][Full Text] [Related]
11. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
Park KR; Yun HM; Quang TH; Oh H; Lee DS; Auh QS; Kim EC
Oncotarget; 2016 Feb; 7(6):6960-71. PubMed ID: 26755649
[TBL] [Abstract][Full Text] [Related]
12. The STAT3/NFIL3 signaling axis-mediated chemotherapy resistance is reversed by Raddeanin A via inducing apoptosis in choriocarcinoma cells.
Peng Z; Zhang C; Zhou W; Wu C; Zhang Y
J Cell Physiol; 2018 Jul; 233(7):5370-5382. PubMed ID: 29215740
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic virotherapy reverses chemoresistance in osteosarcoma by suppressing MDR1 expression.
Sugiu K; Tazawa H; Hasei J; Yamakawa Y; Omori T; Komatsubara T; Mochizuki Y; Kondo H; Osaki S; Fujiwara T; Yoshida A; Kunisada T; Ueda K; Urata Y; Kagawa S; Ozaki T; Fujiwara T
Cancer Chemother Pharmacol; 2021 Sep; 88(3):513-524. PubMed ID: 34114067
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
15. PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
Lei Z; Duan H; Zhao T; Zhang Y; Li G; Meng J; Zhang S; Yan W
Cell Death Dis; 2018 Mar; 9(3):375. PubMed ID: 29515107
[TBL] [Abstract][Full Text] [Related]
16. Notoginsenoside R1 counteracts mesenchymal stem cell-evoked oncogenesis and doxorubicin resistance in osteosarcoma cells by blocking IL-6 secretion-induced JAK2/STAT3 signaling.
Lu M; Xie K; Lu X; Lu L; Shi Y; Tang Y
Invest New Drugs; 2021 Apr; 39(2):416-425. PubMed ID: 33128383
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of miR-506-3p reversed doxorubicin resistance in drug-resistant osteosarcoma cells.
Wang X; Ding R; Fu Z; Yang M; Li D; Zhou Y; Qin C; Zhang W; Si L; Zhang J; Chai Y
Front Pharmacol; 2024; 15():1303732. PubMed ID: 38420199
[No Abstract] [Full Text] [Related]
18. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.
Zhang S; Wang Y; Chen S; Li J
Biomed Pharmacother; 2018 Oct; 106():1396-1403. PubMed ID: 30119212
[TBL] [Abstract][Full Text] [Related]
19. Dynasore suppresses cell proliferation, migration, and invasion and enhances the antitumor capacity of cisplatin via STAT3 pathway in osteosarcoma.
Zhong B; Shi D; Wu F; Wang S; Hu H; Cheng C; Qing X; Huang X; Luo X; Zhang Z; Shao Z
Cell Death Dis; 2019 Sep; 10(10):687. PubMed ID: 31534119
[TBL] [Abstract][Full Text] [Related]
20. Reversal of multidrug resistance by icaritin in doxorubicin-resistant human osteosarcoma cells.
Wang ZD; Wang RZ; Xia YZ; Kong LY; Yang L
Chin J Nat Med; 2018 Jan; 16(1):20-28. PubMed ID: 29425587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
